Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections-Reference-Cited by-同舟云学术

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections

Published:2018-03-05 Issue:3 Volume:14 Page:e1006860
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Wagh Kshitij^ORCID,Seaman Michael S.^ORCID,Zingg Marshall^ORCID,Fitzsimons Tomas^ORCID,Barouch Dan H.,Burton Dennis R.^ORCID,Connors Mark,Ho David D.,Mascola John R.,Nussenzweig Michel C.,Ravetch Jeffrey,Gautam Rajeev,Martin Malcolm A.^ORCID,Montefiori David C.,Korber Bette^ORCID

Funder

Bill and Melinda Gates Foundation (US)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases (US)

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference70 articles.

1. HIV-Host Interactions: Implications for Vaccine Design;BF Haynes;Cell Host Microbe,2016

2. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA;R Elion;Curr Opin HIV AIDS,2016

3. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice;JE Haberer;Curr Opin HIV AIDS,2016

4. Use of broadly neutralizing antibodies for HIV-1 prevention;A Pegu;Immunol Rev,2017

5. Antibodies in HIV-1 vaccine development and therapy;F Klein;Science,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens;PLOS ONE;2024-09-06

3. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives;Clinical Microbiology Reviews;2024-06-13

4. Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV;Pharmaceutics;2024-04-27

5. Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens;2023-12-14